- Home
- VITL vs VNDA Comparison
VITL vs VNDA Comparison
Compare VITL & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | VNDA |
|---|---|---|
| Founded | 2007 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.1M | 387.9M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | VITL | VNDA |
|---|---|---|
| Price | $10.04 | $6.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $32.00 | $14.90 |
| AVG Volume (30 Days) | ★ 3.9M | 1.0M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $759,444,000.00 | $216,105,000.00 |
| Revenue This Year | $19.72 | $21.35 |
| Revenue Next Year | $17.02 | $37.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.26 | 8.72 |
| 52 Week Low | $7.95 | $4.14 |
| 52 Week High | $53.13 | $9.91 |
Technical Indicators
Market Signals| Indicator | VITL | VNDA |
|---|---|---|
| Relative Strength Index (RSI) | 45.13 | 39.38 |
| Support Level | $7.95 | $5.85 |
| Resistance Level | $10.60 | $6.73 |
| Average True Range (ATR) | 0.62 | 0.24 |
| MACD | 0.23 | 0.01 |
| Stochastic Oscillator | 77.19 | 8.61 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.